Binding Mode of Cyclic Chemerin-9 Peptide and ChemerinS157 Protein at CMKLR1.

Annette G Beck-Sickinger, Jens Meiler, Tina Schermeng, Fabian Liessmann, Carla Katharina Ambrosius

Journal: Chembiochem : a European journal of chemical biology 2025;26(1):e202400695

PMID: 39424605

Abstract

The chemokine-like receptor 1 (CMKLR1) is activated by the adipokine and chemoattractant protein chemerin. Cryo-EM structures of chemerin-9-CMKLR1-Gi have been published, where chemerin-9 is the nonapeptide of the C terminus of chemerinS157. Chemerin-9 is as active as the full-length protein in Ca-release but shows differences in equilibrium read-outs. An equally potent cyclic chemerin-9 variant (cC9) was reported previously. Now, we have built a computational model of CMKLR1 to investigate the binding mode of cC9 and chemerinS157 in comparison to chemerin-9. Differences were investigated using CMKLR1 variants. Double-mutant cycle analysis identified CMKLR1-F2.53 as the relevant position for Phe8-binding of cC9. Energy contribution revealed slight differences in Phe8-binding to CMKLR1-F2.53 and space for larger residues. This was confirmed as the chemerin-9 variant with 1-naphthyl-L-alanine at position 8 showed a 4-fold increased potency of 2 nM (pEC=8.6±0.15). While chemerin-9 and cC9 share their interactions at the CMKLR1, chemerinS157 tolerates most mutations of CMKLR1 in the deep binding site. The computational model of chemerinS157 suggests a β-sheet interaction between the N-terminal CMKLR1-segment I25VVL28 and the β-sheet D108KVLGRLVH116 of ChemS157, which was confirmed experimentally. Our data add to the knowledge by identifying the binding mode of chemerinS157 and cC9 at CMKLR1, facilitating the future structure-based drug design.

© 2024 The Author(s). ChemBioChem published by Wiley-VCH GmbH.

Address: Institute of Biochemistry, Faculty of Life Sciences, Leipzig University, Brüderstraße 34, 04103, Leipzig, Germany.; Institute for Drug Discovery, Leipzig University Medical School, Brüderstraße 34, 04103, Leipzig, Germany.; Center for Scalable Data Analytics and Artificial Intelligence ScaDS.AI, Leipzig University, Humboldstraße 25, 04105, Leipzig, Germany.; Institute for Drug Discovery, Leipzig University Medical School, Brüderstraße 34, 04103, Leipzig, Germany.; Center for Scalable Data Analytics and Artificial Intelligence ScaDS.AI, Leipzig University, Humboldstraße 25, 04105, Leipzig, Germany.; Department of Chemistry and Pharmacology, Vanderbilt University, 5144B MRBIII, Nashville, Tennessee, 37235, United States.

Link outs

Free resources

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.